Bispecific antibody therapies are a type of immunotherapy for patients with B-cell non-Hodgkin lymphoma. These therapies provide a valuable new option for patients. There are many standard therapies that are monoclonal antibodies. These therapies treat cancer by binding to a marker on cancer cells and rallying the immune system to destroy them. Bispecific antibodies are … Read more
BCL2 inhibitors are drugs that prompt cancer cells to die by altering the interactions among key proteins within the cells. They were clinically developed, in large part, by researchers at Dana-Farber and have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia … Read more
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma, diagnosed in more than 18,000 people in the U.S. every year. It is a fast-growing lymphoma that can arise in the lymph nodes or, more rarely, in organs such as the spleen, liver, and others. As its name indicates, DLBCL involves the … Read more
Throughout the 20 years Robert Jenkins has been living with follicular lymphoma, he has been through many different treatments — from traditional chemotherapy protocols to innovative approaches like CAR T-cell therapy and bispecific antibodies. His lengthy survivorship has allowed Jenkins to benefit from new advances as they’ve emerged, and along with his wife, Lorna, one … Read more
Dana-Farber researchers have found that a transcription factor called SOX17 gives colon cancer a safe space to develop.
Lung cancer is on the rise in young people, particularly those who are assigned female at birth (AFAB).
As Chen Wen Ye nears five years of being cancer-free, Chen has committed herself to helping others facing such issues.
When Youling Sun was diagnosed in Shanghai, China, with acute myeloid leukemia (AML) in 2018, he called his son, Conghao, in Boston, for advice. His son’s message was unequivocal: Come to Boston for your treatment. Today, Sun, a retired office worker from Shanghai, has multiple reasons to be thankful he took that advice — both … Read more
Ruth Nelson struggled with her new breast cancer diagnosis mentally and physically. On treatment, her cardiac health faltered, her blood pressure spiked, and she experienced an unexplained episode in which she briefly lost her speech. And on top of that, she felt as if she were “a problem to be managed” by her friends and … Read more
Stories of young adults being diagnosed with colorectal cancer are becoming more common as the rates continue to rise among adults between 20 and 49.
Physicians have long known that there is a link between diabetes and pancreatic cancer.
After treatment at Dana-Farber, Dena Ofengeim was able to get on her bike, train with her friends, and complete the Pan-Mass Challenge.
A melanoma therapeutic vaccine is a type of personalized cancer vaccine that is intended to train the immune system to fight cancer cells in a way that lasts many years. These novel vaccines are personally tailored to recognize the mutations present in an individual’s tumor cells. They are different from vaccines for infectious diseases, which … Read more
Over the past 30 years, outcomes have improved dramatically for women with breast cancer. There are many new treatments, including hormone therapies and CDK4/6 inhibitors. In contrast, there has been no improvement in the outcomes for men with breast cancer. And current guidelines don’t support the use of newer therapies in men. “If we do … Read more
As a veteran scuba diver who has donned her wetsuit around the globe, Stephanie Lafontaine is never more at peace than when deep below the water’s surface. Even if she’s sharing the depths with sharks, she considers it her happy place. So when Lafontaine, 42, learned in April 2019 that she had inflammatory breast cancer … Read more
A pair of subversives, the genes BTK and PLCG2 are often mutated in chronic lymphocytic leukemia (CLL) that is resistant to the drug ibrutinib. But how common are these genetic alterations and to what extent do they contribute to ibrutinib resistance? The answers will help doctors determine which targeted therapies are most likely to help … Read more
As a systems operator who works to help maintain the electrical grid for New York state, Brian Houlihan, 46, is used to getting power to the people. But when the multiple myeloma he has lived with since 2011 stopped responding to chemotherapy, it was Houlihan who needed a recharge. He got it, through an innovative … Read more
Sally Johnston cannot be slowed down. She just recently returned from a month-long trip to South Africa for a safari, and Namibia to visit a longtime friend, and is already planning her next excursion. The 74-year-old survivor has always been active, and she says it’s time to achieve her goal of visiting all seven continents. … Read more
Arliene T. Penn entered the Mrs. Globe pageant in 2023 not to win a title, but rather to spread a very important message on a very large stage. In the end, she did both. Competing as Mrs. British Virgin Islands, Penn reached the semifinals of the international event. Far more important to her, however, was … Read more
An ovarian cyst is not the same as ovarian cancer. Benign ovarian cysts are extremely common, while ovarian cancer is rare. They do share symptoms, such as abdominal bloating, pressure, pain, or swelling. A gynecologist can help you determine if you have a benign ovarian cyst and if you need treatment. Many cysts go away … Read more